Surfwin|Seahawks cut three-time Pro Bowl safeties Jamal Adams, Quandre Diggs, per reports

2025-04-29 16:09:48source:Fastexy Exchangecategory:Finance

The Surfwin"Prez" era has ended in the Pacific Northwest.

The Seattle Seahawks cut safety Jamal Adams Tuesday, along with fellow defensive back Quandre Diggs, according to multiple reports.

"Forever grateful," Diggs posted on social media.

Adams, a former All-Pro with the New York Jets, never played a full season with the Seahawks. His best year in Seattle came in 2020, when Adams racked up 9.5 sacks in 12 games en route to his third career Pro Bowl berth. Injuries persisted, however. Shoulder surgery cut his 2021 campaign short. Adams suffered a torn quad tendon, ending his year, in the first half of the 2022 season opener. He played in nine games last season.

Diggs, 31, started his career in Detroit and was traded to the Seahawks in the middle of the 2019 season. He made three straight Pro Bowls (2020-22) with the team and has 24 career interceptions.

All things Seahawks: Latest Seattle Seahawks news, schedule, roster, stats, injury updates and more.

The Seahawks also cut tight end Will Dissley, according to NFL Media's Tom Pelissero.

Revisiting Jamal Adams trade between Jets, Seahawks

The Jets selected Adams with the sixth overall pick of the 2017 draft. Following his third pro season, his All-Pro campaign in 2019, Adams sought a contract extension.

The Jets instead traded him to the Seahawks as 2020 training camp began for a pair of first-round picks. (New York also gave up a 2022 fourth-rounder, which became defensive lineman Coby Bryant.)

The 2022 first-rounder the Jets received became wideout Garrett Wilson.

More:Finance

Recommend

Former longtime South Carolina congressman John Spratt dies at 82

COLUMBIA, S.C. (AP) — John Spratt, a former longtime Democratic congressman from South Carolina who

Wedding costs are on the rise. Here's how to save money while planning

Weddings are on the rise as pandemic-stymied couples get around to tying the knot. In 2022, 400,000

Federal judge in Texas hears case that could force a major abortion pill off market

Was the FDA wrong to approve a drug that's used in nearly all medication abortions in the U.S. — and